MatherS.J., EllisonD., BentleyS., GranowskaM., BrittonK.E.Antibody labelling with Tc-99m. Nucl Med Commun1989; 10: 245.
3.
BaumR.P., HertelA., LorenzM., SchwarzA., EnckeA., HorG.99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results. Nucl Med Commun1989; 10: 345–52.
4.
BaumR.P., MaulF.D., SchwarzA., HertelA., BossletK., HorG.Diagnosis and treatment of stage IV neuroblastoma with Tc-99m and 1-131 monoclonal antibody BW 575/9. J Nucl Med1989; 30: 904.
5.
BrownB.A., DavisG.L., Saltzgaber-MullerJ.Tumour specific genetically engineered murine/human chimeric monoclonal antibody. Cancer Res1987; 47: 3577–83.
6.
ReichmannL., ClarkeM., WaldmannH., WinterG.Reshaping human antibodies for therapy. Nature1988; 332: 323–7.
7.
JanssenJamjl, BlankestynR., BlyenbergB.G.Effects of immunoscintigraphy with monoclonal antibodies in assays of hormones and tumour markers. Brit Med J1989; 298: 1511–3.
8.
van KroonenburghMjpg, PauwelsE.K.J.Human immunological response to mouse monoclonal antibodies in the treatment or diagnosis of malignant disease. Nucl Med Commun1988; 9: 919–30.
